Literature DB >> 23201597

Visceral adiposity in gastrointestinal and hepatic carcinogenesis.

Roslyn Vongsuvanh1, Jacob George, Liang Qiao, David van der Poorten.   

Abstract

There is emerging evidence that the association between obesity and cancer is mediated by visceral rather than generalised body fat. Visceral fat has been directly implicated in the risk and progression of several gastrointestinal cancers including colorectal, oesophageal, pancreatic and hepatocellular carcinomas. Excess visceral adipose tissue induces a state of chronic systemic inflammation and altered metabolic activity that promotes a pro-oncogenic environment. This review examines the evidence linking visceral fat in gastrointestinal and hepatic carcinogenesis and explores our current understanding of the mechanisms underlying this relationship.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23201597     DOI: 10.1016/j.canlet.2012.11.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.

Authors:  Manasi S Shah; David R Fogelman; Kanwal Pratap Singh Raghav; John V Heymach; Hai T Tran; Zhi-Qin Jiang; Scott Kopetz; Carrie R Daniel
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

Review 2.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

Review 3.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

4.  A Screening Study of Potential Carcinogen Biomarkers After Surgical Treatment of Obesity.

Authors:  Luciana Teixeira de Siqueira; Marcela Silvestre Outtes Wanderley; Roberto Afonso da Silva; Adriana da Silva Andrade Pereira; José Luiz de Lima Filho; Álvaro Antônio Bandeira Ferraz
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 5.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

Review 6.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

7.  Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.

Authors:  Yuri V Postnikov; Takashi Furusawa; Diana C Haines; Valentina M Factor; Michael Bustin
Journal:  Mol Cancer Res       Date:  2013-12-02       Impact factor: 5.852

8.  Abdominal adipose tissue in MGUS and multiple myeloma.

Authors:  Joyce Veld; Elizabeth K O'Donnell; Michaela R Reagan; Andrew J Yee; Martin Torriani; Clifford J Rosen; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2016-06-25       Impact factor: 2.199

9.  Influence of dietary fat type on benzo(a)pyrene [B(a)P] biotransformation in a B(a)P-induced mouse model of colon cancer.

Authors:  Deacqunita L Diggs; Jeremy N Myers; Leah D Banks; Mohammad S Niaz; Darryl B Hood; L Jackson Roberts; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

10.  Sex and Ethnic Differences in the Association of Obesity With Risk of Hepatocellular Carcinoma.

Authors:  Veronica Wendy Setiawan; Unhee Lim; Loren Lipworth; Shelly C Lu; John Shepherd; Thomas Ernst; Lynne R Wilkens; Brian E Henderson; Loïc Le Marchand
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.